(Circulation. 1999;100:2473.)
© 1999 American Heart Association, Inc.
Brief Rapid Communication |
Novel Modulator for Endothelial Adhesion Molecules
Adipocyte-Derived Plasma Protein Adiponectin
From the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. Drs Ouchi and Kihara contributed equally to the work.
Correspondence to Noriyuki Ouchi, MD, Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, 2-2, Yamada-oka, Suita, Osaka, 565-0871, Japan. E-mail ouchi{at}imed2.med.osaka-u.ac.jp
Background—Among the many adipocyte-derived endocrine factors, we recently found an adipocyte-specific secretory protein, adiponectin, which was decreased in obesity. Although obesity is associated with increased cardiovascular mortality and morbidity, the molecular basis for the link between obesity and vascular disease has not been fully clarified. The present study investigated whether adiponectin could modulate endothelial function and relate to coronary disease.
Methods and Results—For the in vitro study, human aortic
endothelial cells (HAECs) were preincubated for 18
hours with the indicated amount of adiponectin, then exposed to tumor
necrosis factor-
(TNF-) (10 U/mL) or vehicle for the times
indicated. The adhesion of human monocytic cell line THP-1 cells to
HAECs was determined by adhesion assay. The surface expression of
vascular cell adhesion molecule-1 (VCAM-1),
endothelial-leukocyte adhesion molecule-1 (E-selectin),
and intracellular adhesion molecule-1 (ICAM-1) was measured by cell
ELISA. Physiological concentrations of adiponectin
dose-dependently inhibited TNF-–induced THP-1 adhesion and
expression of VCAM-1, E-selectin, and ICAM-1 on HAECs. For the in vivo
study, the concentrations of adiponectin in human plasma were
determined by a sandwich ELISA system that we recently developed.
Plasma adiponectin concentrations were significantly lower in patients
with coronary artery disease than those in age- and body mass
index–adjusted control subjects.
Conclusions—These observations suggest that adiponectin modulates endothelial inflammatory response and that the measurement of plasma adiponectin levels may be helpful in assessment of CAD risk.
Key Words: endothelium • cell adhesion molecules • coronary disease • adiponectin
This article has been cited by other articles:
 |
|
 |
|
  P. Li, R. Shibata, K. Unno, M. Shimano, M. Furukawa, T. Ohashi, X. Cheng, K. Nagata, N. Ouchi, and T. Murohara Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone Hypertension, January 1, 2010; 55(1): 69 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Aminzadeh, M. V. Pahl, C. H. Barton, N. S. Doctor, and N. D. Vaziri Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-{alpha} in visceral adipocytes Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3626 - 3631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Paz-Pacheco, M. A. Lim-Abrahan, R. A. G. Sy, G. V. Jasul, C. M. C. Sison, and A. F. Laurel Adiponectin levels and its association with hyperglycaemia in adult Filipino participants in the 2003--04 National Nutrition and Health Survey Diabetes and Vascular Disease Research, October 1, 2009; 6(4): 231 - 237. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Mack, R. S. BelAiba, T. Djordjevic, A. Gorlach, H. Hauner, and B. L. Bader Functional analyses reveal the greater potency of preadipocytes compared with adipocytes as endothelial cell activator under normoxia, hypoxia, and TNF{alpha} exposure Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E735 - E748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Summer, C. A. Fiack, Y. Ikeda, K. Sato, D. Dwyer, N. Ouchi, A. Fine, H. W. Farber, and K. Walsh Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease Am J Physiol Lung Cell Mol Physiol, September 1, 2009; 297(3): L432 - L438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Barresi, M Grosso, G Giuffre, G Tuccari, and G Barresi The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma J. Clin. Pathol., August 1, 2009; 62(8): 705 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Karastergiou, V. Mohamed-Ali, M. Jahangiri, and J.-C. Kaski Review: Adiponectin for prediction of cardiovascular risk? The British Journal of Diabetes & Vascular Disease, July 1, 2009; 9(4): 150 - 154. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Ohashi, N. Ouchi, K. Sato, A. Higuchi, T.-o Ishikawa, H. R. Herschman, S. Kihara, and K. Walsh Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism Mol. Cell. Biol., July 1, 2009; 29(13): 3487 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Higuchi, K. Ohashi, S. Kihara, K. Walsh, and N. Ouchi Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-{alpha} Expression Circ. Res., May 8, 2009; 104(9): 1058 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Park, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor {gamma} Transcription J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 571 - 579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Frankel, R. S. Vasan, R. B. D'Agostino Sr, E. J. Benjamin, D. Levy, T. J. Wang, and J. B. Meigs Resistin, Adiponectin, and Risk of Heart Failure: The Framingham Offspring Study J. Am. Coll. Cardiol., March 3, 2009; 53(9): 754 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sood, C. Qualls, J. Seagrave, C. Stidley, T. Archibeque, M. Berwick, and M. Schuyler Effect of Specific Allergen Inhalation on Serum Adiponectin in Human Asthma Chest, February 1, 2009; 135(2): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Moukdar, J. Robidoux, O. Lyght, J. Pi, K. W. Daniel, and S. Collins Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice J. Lipid Res., January 1, 2009; 50(1): 59 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zhang, Y. Wang, Y. Fan, Z. Tang, and N. Wang Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikegami, K. Inukai, K. Imai, Y. Sakamoto, H. Katagiri, S. Kurihara, T. Awata, and S. Katayama Adiponectin Upregulates Ferritin Heavy Chain in Skeletal Muscle Cells Diabetes, January 1, 2009; 58(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Deepa and L. Q. Dong APPL1: role in adiponectin signaling and beyond Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E22 - E36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Stehno-Bittel Intricacies of Fat Physical Therapy, November 1, 2008; 88(11): 1265 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Michaelsson, L. Lind, J. Frystyk, A. Flyvbjerg, R. Gedeborg, C. Berne, B. Zethelius, H. Mallmin, S. Soderberg, and H. Melhus Serum Adiponectin in Elderly Men Does Not Correlate with Fracture Risk J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4041 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Sood, X Cui, C Qualls, W S Beckett, M D Gross, M W Steffes, L J Smith, and D R Jacobs Jr Association between asthma and serum adiponectin concentration in women Thorax, October 1, 2008; 63(10): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maiolino, M. Cesari, D. Sticchi, M. Zanchetta, L. Pedon, K. Antezza, A. C. Pessina, and G. P. Rossi Plasma Adiponectin for Prediction of Cardiovascular Events and Mortality in High-Risk Patients J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3333 - 3340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Zyromski, A. Mathur, H. A. Pitt, D. Lu, J. T. Gripe, J. J. Walker, K. Yancey, T. E. Wade, and D. A. Swartz-Basile A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G552 - G558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Leth, K. K. Andersen, J. Frystyk, L. Tarnow, P. Rossing, H.-H. Parving, and A. Flyvbjerg Elevated Levels of High-Molecular-Weight Adiponectin in Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3186 - 3191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pini, M. E. Gove, J. A. Sennello, J. W. P. M. van Baal, L. Chan, and G. Fantuzzi Role and Regulation of Adipokines during Zymosan-Induced Peritoneal Inflammation in Mice Endocrinology, August 1, 2008; 149(8): 4080 - 4085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Malyszko, J.S. Malyszko, P. Kozminski, K. Pawlak, and M. Mysliwiec Adipokines, Linking Adipocytes and Vascular Function in Hemodialyzed Patients, May Also Be Possibly Related to CD146, a Novel Adhesion Molecule Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 338 - 345. [Abstract] [PDF]
|
|
|
|
|
|
C. Natal, P. Restituto, C. Inigo, I. Colina, J. Diez, and N. Varo The Proinflammatory Mediator CD40 Ligand Is Increased in the Metabolic Syndrome and Modulated by Adiponectin J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2319 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Olufadi and C D Byrne Clinical and laboratory diagnosis of the metabolic syndrome J. Clin. Pathol., June 1, 2008; 61(6): 697 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Atzmon, T. I. Pollin, J. Crandall, K. Tanner, C. B. Schechter, P. E. Scherer, M. Rincon, G. Siegel, M. Katz, R. B. Lipton, et al. Adiponectin Levels and Genotype: A Potential Regulator of Life Span in Humans J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 447 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. G. Kaklamani, M. Sadim, A. Hsi, K. Offit, C. Oddoux, H. Ostrer, H. Ahsan, B. Pasche, and C. Mantzoros Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk Cancer Res., May 1, 2008; 68(9): 3178 - 3184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Skurk, F. Wittchen, L. Suckau, H. Witt, M. Noutsias, H. Fechner, H.-P. Schultheiss, and W. Poller Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy Eur. Heart J., May 1, 2008; 29(9): 1168 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Q. Xu, K. Mahadev, X. Wu, L. Fuchsel, S. Donnelly, R. G. Scalia, and B. J. Goldstein Adiponectin Protects Against Angiotensin II or Tumor Necrosis Factor {alpha}-Induced Endothelial Cell Monolayer Hyperpermeability: Role of cAMP/PKA Signaling Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 899 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, S. Yamaguchi, T. Shimoyama, H. Seki, K. Miyokawa, H. Katsuta, T. Tanaka, K. Yoshimoto, H. Ohno, S. Nagamatsu, et al. JNK- and I{kappa}B-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E898 - E909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells Cardiovasc Res, May 1, 2008; 78(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-K. Son, M. Akishita, K. Iijima, K. Kozaki, K. Maemura, M. Eto, and Y. Ouchi Adiponectin Antagonizes Stimulatory Effect of Tumor Necrosis Factor-{alpha} on Vascular Smooth Muscle Cell Calcification: Regulation of Growth Arrest-Specific Gene 6-Mediated Survival Pathway by Adenosine 5'-Monophosphate-Activated Protein Kinase Endocrinology, April 1, 2008; 149(4): 1646 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Cheurfa, D. Dubois-Laforgue, D. A.F. Ferrarezi, A. F. Reis, G. M. Brenner, C. Bouche, C. Le Feuvre, F. Fumeron, J. Timsit, M. Marre, et al. The Common -866G>A Variant in the Promoter of UCP2 Is Associated With Decreased Risk of Coronary Artery Disease in Type 2 Diabetic Men Diabetes, April 1, 2008; 57(4): 1063 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakagawa, K. Kishida, S. Kihara, M. Sonoda, A. Hirata, A. Yasui, H. Nishizawa, T. Nakamura, R. Yoshida, I. Shimomura, et al. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E778 - E784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J Williams, N. Mitsiades, E. Sozopoulos, A. Hsi, A. Wolk, A.-P. Nifli, S. Tseleni-Balafouta, and C. S Mantzoros Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors Endocr. Relat. Cancer, March 1, 2008; 15(1): 289 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Miller, P. Siripurkpong, J. Hawes, A. Majdalawieh, H.-S. Ro, and R. S. McLeod The trans-10, cis-12 isomer of conjugated linoleic acid decreases adiponectin assembly by PPAR{gamma}-dependent and PPAR{gamma}-independent mechanisms J. Lipid Res., March 1, 2008; 49(3): 550 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zoccali Endothelial dysfunction in CKD: a new player in town? Nephrol. Dial. Transplant., March 1, 2008; 23(3): 783 - 785. [Full Text] [PDF]
|
|
|
|
|
|
R. Schnabel, C. M. Messow, E. Lubos, C. Espinola-Klein, H. J. Rupprecht, C. Bickel, C. Sinning, S. Tzikas, T. Keller, S. Genth-Zotz, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur. Heart J., March 1, 2008; 29(5): 649 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tabara, H. Osawa, R. Kawamoto, R. Tachibana-Iimori, M. Yamamoto, J. Nakura, T. Miki, H. Makino, and K. Kohara Reduced High-Molecular-Weight Adiponectin and Elevated High-Sensitivity C-Reactive Protein Are Synergistic Risk Factors for Metabolic Syndrome in a Large-Scale Middle-Aged to Elderly Population: the Shimanami Health Promoting Program Study J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, H. Hayashi, M. Mori, H. Koriyama, Y. Baba, O. Yasuda, H. Rakugi, et al. Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells Am. J. Pathol., March 1, 2008; 172(3): 818 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Chandrasekar, D. N. Patel, S. Mummidi, J.-w. Kim, R. A. Clark, and A. J. Valente Interleukin-18 Suppresses Adiponectin Expression in 3T3-L1 Adipocytes via a Novel Signal Transduction Pathway Involving ERK1/2-dependent NFATc4 Phosphorylation J. Biol. Chem., February 15, 2008; 283(7): 4200 - 4209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Cave, R. T. Hurt, T. H. Frazier, P. J. Matheson, R. N. Garrison, C. J. McClain, and S. A. McClave Obesity, Inflammation, and the Potential Application of Pharmaconutrition Nutr Clin Pract, February 1, 2008; 23(1): 16 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Matsumoto, S. Ishikawa, and E. Kajii Association of Adiponectin With Cerebrovascular Disease: A Nested Case-Control Study Stroke, February 1, 2008; 39(2): 323 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishimura, Y. Izumiya, A. Higuchi, R. Shibata, J. Qiu, C. Kudo, H. K. Shin, M. A. Moskowitz, and N. Ouchi Adiponectin Prevents Cerebral Ischemic Injury Through Endothelial Nitric Oxide Synthase-Dependent Mechanisms Circulation, January 15, 2008; 117(2): 216 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, K. Mahadev, L. Fuchsel, R. Ouedraogo, S.-q. Xu, and B. J. Goldstein Adiponectin suppresses I{kappa}B kinase activation induced by tumor necrosis factor-{alpha} or high glucose in endothelial cells: role of cAMP and AMP kinase signaling Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1836 - E1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L'Abbate, D. Neglia, C. Vecoli, M. Novelli, V. Ottaviano, S. Baldi, R. Barsacchi, A. Paolicchi, P. Masiello, G. S. Drummond, et al. Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3532 - H3541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Golledge, P. Clancy, K. Jamrozik, and P. E. Norman Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study Circulation, November 13, 2007; 116(20): 2275 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Tang, Y.-C. Chiu, T.-W. Tan, R.-S. Yang, and W.-M. Fu Adiponectin Enhances IL-6 Production in Human Synovial Fibroblast via an AdipoR1 Receptor, AMPK, p38, and NF-{kappa}B Pathway J. Immunol., October 15, 2007; 179(8): 5483 - 5492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Galler, G. Gelbrich, J. Kratzsch, N. Noack, T. Kapellen, and W. Kiess Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study Eur. J. Endocrinol., October 1, 2007; 157(4): 481 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stirban, M. Negrean, B. Stratmann, C. Gotting, J. Salomon, K. Kleesiek, and D. Tschoepe Adiponectin Decreases Postprandially Following a Heat-Processed Meal in Individuals With Type 2 Diabetes: An effect prevented by benfotiamine and cooking method Diabetes Care, October 1, 2007; 30(10): 2514 - 2516. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Maahs, L. G. Ogden, J. K. Snell-Bergeon, G. L. Kinney, R. P. Wadwa, J. E. Hokanson, D. Dabelea, A. Kretowski, R. H. Eckel, and M. Rewers Determinants of Serum Adiponectin in Persons with and without Type 1 Diabetes Am. J. Epidemiol., September 15, 2007; 166(6): 731 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohashi, H. Iwatani, S. Kihara, Y. Nakagawa, N. Komura, K. Fujita, N. Maeda, M. Nishida, F. Katsube, I. Shimomura, et al. Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1910 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Kim, K.-Y. Hur, H.-J. Kim, W.-S. Shim, C.-W. Ahn, S.-W. Park, Y.-W. Cho, S.-K. Lim, H.-C. Lee, and B.-S. Cha The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment Eur. J. Endocrinol., August 1, 2007; 157(2): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yuan, X. Chen, Q. Ma, J. Qiao, R. Li, X. Li, S. Li, J. Tang, L. Zhou, H. Song, et al. C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes J. Endocrinol., August 1, 2007; 194(2): 275 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari, K. Narkiewicz, R. De Toni, E. Aldighieri, C. J. Williams, and G. P. Rossi Heritability of Plasma Adiponectin Levels and Body Mass Index in Twins J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3082 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Shibata, K. Sato, M. Kumada, Y. Izumiya, M. Sonoda, S. Kihara, N. Ouchi, and K. Walsh Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment Cardiovasc Res, June 1, 2007; 74(3): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Musaad and E. N. Haynes Biomarkers of Obesity and Subsequent Cardiovascular Events Epidemiol. Rev., May 10, 2007; (2007) mxm005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Flynn, B. K. McFarlin, and M. M. Markofski State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235. [Abstract] [PDF]
|
|
|
|
|
|
R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment? Eur. Heart J., April 2, 2007; 28(8): 929 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-J. Li, H.-W. Sun, F.-L. Zhu, L. Chen, Y.-Y. Rong, Y. Zhang, and M. Zhang Local adiponectin treatment reduces atherosclerotic plaque size in rabbits J. Endocrinol., April 1, 2007; 193(1): 137 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Szmitko, H. Teoh, D. J. Stewart, and S. Verma Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1655 - H1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res, April 1, 2007; 74(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Falasca, M. R. Manigrasso, D. Racciatti, P. Zingariello, M. Dalessandro, C. Ucciferri, P. Mancino, M. Marinopiccoli, C. Petrarca, P. Conti, et al. Associations between Hypertriglyceridemia and Serum Ghrelin, Adiponectin, and IL-18 Levels in HIV-infected Patients. Ann. Clin. Lab. Sci., December 1, 2006; 36(1): 59 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Trujillo and P. E. Scherer Adipose Tissue-Derived Factors: Impact on Health and Disease Endocr. Rev., December 1, 2006; 27(7): 762 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Teta, M. Maillard, A. Tedjani, J. Passlick-Deetjen, and M. Burnier The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes Nephrol. Dial. Transplant., November 28, 2006; (2006) gfl698v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto Type 1 diabetes and coronary artery disease. Diabetes Care, November 1, 2006; 29(11): 2528 - 2538. [Full Text] [PDF]
|
|
|
|
|
|
K. Ikeda, H. Maegawa, S. Ugi, Y. Tao, Y. Nishio, S. Tsukada, S. Maeda, and A. Kashiwagi Transcription Factor Activating Enhancer-binding Protein-2beta: A NEGATIVE REGULATOR OF ADIPONECTIN GENE EXPRESSION J. Biol. Chem., October 20, 2006; 281(42): 31245 - 31253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cavusoglu, C. Ruwende, V. Chopra, S. Yanamadala, C. Eng, L. T. Clark, D. J. Pinsky, and J. D. Marmur Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur. Heart J., October 1, 2006; 27(19): 2300 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Soccio, Y.-Y. Zhang, S. Bacci, W. Mlynarski, G. Placha, G. Raggio, R. Di Paola, A. Marucci, M. T. Johnstone, E. V. Gervino, et al. Common Haplotypes at the Adiponectin Receptor 1 (ADIPOR1) Locus Are Associated With Increased Risk of Coronary Artery Disease in Type 2 Diabetes. Diabetes, October 1, 2006; 55(10): 2763 - 2770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J George, S Patal, D Wexler, Y Sharabi, E Peleg, Y Kamari, E Grossman, D Sheps, G Keren, and A Roth Circulating adiponectin concentrations in patients with congestive heart failure Heart, October 1, 2006; 92(10): 1420 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Otsuka, S. Sugiyama, S. Kojima, H. Maruyoshi, T. Funahashi, K. Matsui, T. Sakamoto, M. Yoshimura, K. Kimura, S. Umemura, et al. Plasma Adiponectin Levels Are Associated With Coronary Lesion Complexity in Men With Coronary Artery Disease J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1155 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Yoon, G. Y. Lee, J.-J. Chung, Y. H. Ahn, S. H. Hong, and J. B. Kim Adiponectin Increases Fatty Acid Oxidation in Skeletal Muscle Cells by Sequential Activation of AMP-Activated Protein Kinase, p38 Mitogen-Activated Protein Kinase, and Peroxisome Proliferator-Activated Receptor {alpha} Diabetes, September 1, 2006; 55(9): 2562 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, G. Wannamethee, N. Sarwar, J. Tchernova, L. Cherry, A. M. Wallace, J. Danesh, and P. H. Whincup Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis Circulation, August 15, 2006; 114(7): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Trayhurn and C. Bing Appetite and energy balance signals from adipocytes Phil Trans R Soc B, July 29, 2006; 361(1471): 1237 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakano, S. Tajima, A. Yoshimi, H. Akiyama, M. Tsushima, T. Tanioka, T. Negoro, M. Tomita, and T. Tobe A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin J. Lipid Res., July 1, 2006; 47(7): 1572 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Herder, H. Hauner, B. Haastert, K. Rohrig, W. Koenig, H. Kolb, S. Muller-Scholze, B. Thorand, R. Holle, and W. Rathmann Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin?: Results From the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4) Diabetes Care, July 1, 2006; 29(7): 1626 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nishimura, T. Hashimoto, H. Kobayashi, S. Yamazaki, K. Okino, H. Fujita, N. Inoue, H. Takahashi, and T. Ono Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1640 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ouedraogo, X. Wu, S.-Q. Xu, L. Fuchsel, H. Motoshima, K. Mahadev, K. Hough, R. Scalia, and B. J. Goldstein Adiponectin Suppression of High-Glucose-Induced Reactive Oxygen Species in Vascular Endothelial Cells: Evidence for Involvement of a cAMP Signaling Pathway Diabetes, June 1, 2006; 55(6): 1840 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohashi, S. Kihara, N. Ouchi, M. Kumada, K. Fujita, A. Hiuge, T. Hibuse, M. Ryo, H. Nishizawa, N. Maeda, et al. Adiponectin Replenishment Ameliorates Obesity-Related Hypertension Hypertension, June 1, 2006; 47(6): 1108 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qi, A. Doria, J. E. Manson, J. B. Meigs, D. Hunter, C. S. Mantzoros, and F. B. Hu Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes, May 1, 2006; 55(5): 1512 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease Clin. Chem., May 1, 2006; 52(5): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bruun, J. W. Helge, B. Richelsen, and B. Stallknecht Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E961 - E967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Bernstein, J. Berry, S. Kim, B. Canavan, and S. K. Grinspoon Effects of Etanercept in Patients With the Metabolic Syndrome. Arch Intern Med, April 24, 2006; 166(8): 902 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ekmekci and O. B. Ekmekci The Role of Adiponectin in Atherosclerosis and Thrombosis Clinical and Applied Thrombosis/Hemostasis, April 1, 2006; 12(2): 163 - 168. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ehling, A. Schaffler, H. Herfarth, I. H. Tarner, S. Anders, O. Distler, G. Paul, J. Distler, S. Gay, J. Scholmerich, et al. The Potential of Adiponectin in Driving Arthritis J. Immunol., April 1, 2006; 176(7): 4468 - 4478. [Abstract] [Full Text] [PDF]
|
|